Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/15/2010EP1748774B1 Compositions comprising flavonoids and tocotrienols and uses thereof
12/15/2010EP1748769B1 Antiviral composition comprising p-menthane-3,8-diol
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1720610B1 Alcohol metabolism moderating composition
12/15/2010EP1715865B9 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
12/15/2010EP1694645B1 Amlodipine gentisate and a method of its preparation
12/15/2010EP1680112B1 N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
12/15/2010EP1677808B1 Combined preparation for treating sepsis
12/15/2010EP1640025B1 Composition for external use
12/15/2010EP1634883B1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
12/15/2010EP1605937B1 Treatment of proliferative diseases with epothilone derivatives and radiation
12/15/2010EP1594441B1 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
12/15/2010EP1558254B1 Use of 4-aminoquinolines compounds for the treatment of inflammatory disorders of the eye
12/15/2010EP1556345B1 Vitamin d analogues, compositions comprising said analogues and their use
12/15/2010EP1534667B1 Muscarinic agonists
12/15/2010EP1530462B1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
12/15/2010EP1501822B1 Phthalazinone derivatives
12/15/2010EP1499582B1 Method for chlorinating tertiary alcohols
12/15/2010EP1487485B1 Imidazoquinoline adjuvants for dna vaccines
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010EP1395289B1 Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists
12/15/2010EP1276463B1 Hemostatic agent, method and carrier for applying a blood clotting agent
12/15/2010EP1196050B2 Compositions for providing and maintaining energy and mental alertness
12/15/2010CN201668750U Compound amlodipine, valsartan and hydrochlorothiazide capsule
12/15/2010CN1993362B 稠合的杂环化合物 Fused heterocyclic compound
12/15/2010CN1993324B 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
12/15/2010CN1989985B Chuanxiong rhizome effective ingredient, preparing method, preparation and use thereof
12/15/2010CN1989955B Biphenylacetic acid cataplasms
12/15/2010CN1988848B Carboranylporphyrins and uses thereof
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1984657B Using method and compositions comprising immunomodulatory compounds for treatment and management of myeloproliferative diseases
12/15/2010CN1981811B Danshen effective component, its preparation, making method and usage
12/15/2010CN1969924B Pharmaceutical composition of Silibinin and isatis root
12/15/2010CN1968699B Acyclovir formulations
12/15/2010CN1961889B Application of isoliquiritigenin in preparation of medicament for preventing and/or treating depression
12/15/2010CN1956720B Combination medication for treating HIV infection
12/15/2010CN1956716B Medicine capable of inhibiting activation of transcription factor KLF5
12/15/2010CN1946394B Injectable composition for the treatment of cancers
12/15/2010CN1939357B Preparation of Ginkgo Damo injection
12/15/2010CN1935134B Combination comprising combretastatin and anticancer agents
12/15/2010CN1933840B Use of a phenothiazine derivative for preventing and/or treating hearing loss
12/15/2010CN1929829B (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
12/15/2010CN1919848B bilobalide K and complex thereof, preparation method and use for the same
12/15/2010CN1919222B Process for preparing notoginsen triterpenes
12/15/2010CN1917866B Use of treprostinil, its derivant or pharmaceutically acceptable salt, in preparing medicine to treat and prevent ischemic lesions
12/15/2010CN1916009B Process for preparing amine platinum complexes
12/15/2010CN1915429B Combinations of the peroxisome proliferator-activated receptor (ppar) activator and sterol absorption inhibitor
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN1889942B Drug containing (2R)-2-propyloctanoic acid as the active ingredient
12/15/2010CN1883456B Flavor-hidden pharmaceutical granule, preparation method and use thereof
12/15/2010CN1882567B Quinazoline derivatives as tyrosine kinase inhibitors
12/15/2010CN1867359B Methylphenidate solution and its pharmaceutical uses and production
12/15/2010CN1863774B Compounds and compositions as protein kinase inhibitors
12/15/2010CN1829489B Use of buprenorphine in preparing medicine for Preoperative treatment of post operative pain
12/15/2010CN1824292B Medicine for improving brain function its preparation method and use
12/15/2010CN1816339B Metabolite of quetiapine
12/15/2010CN1785248B Effervescent of compounding medicines
12/15/2010CN1778342B Chinese medicine composition for treating coronary heart disease
12/15/2010CN1778338B Chinese medicine composition for treating coronary heart disease and angina cordis
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/15/2010CN1681481B Medicaments containing vardenafil hydrochloride trihydrate
12/15/2010CN1602837B Deodorant composition
12/15/2010CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents
12/15/2010CN101918577A Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same
12/15/2010CN101918540A Use of LINGO-4 antagonists in the treatment of conditions involving demyelination
12/15/2010CN101918473A Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery
12/15/2010CN101918427A 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/15/2010CN101918426A 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/15/2010CN101918423A Organic compounds
12/15/2010CN101918418A Solid forms of tenofovir disoproxil
12/15/2010CN101918417A Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same
12/15/2010CN101918416A Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
12/15/2010CN101918412A Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c
12/15/2010CN101918411A Process for the preparation of asenapine and intermediate products used in said process
12/15/2010CN101918410A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
12/15/2010CN101918409A Biaryl substituted diazabicycloalkane derivatives
12/15/2010CN101918408A Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
12/15/2010CN101918407A Beta-lactamase inhibitors
12/15/2010CN101918404A 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives
12/15/2010CN101918403A Pyrazolo-pyridines as tyrosine kinase inhibitors
12/15/2010CN101918402A Octahydroquinoli zines for antidiabetic treatment
12/15/2010CN101918399A Amino 1,2,4-triazole derivatives as modulators of MGLUR5
12/15/2010CN101918398A 4,4-disubstituted piperidines
12/15/2010CN101918396A Organic compounds
12/15/2010CN101918395A Triazole oxadiazoles derivatives
12/15/2010CN101918392A Pyrazole derivatives as 5-LO inhibitors
12/15/2010CN101918391A Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
12/15/2010CN101918390A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
12/15/2010CN101918389A Inhibitors of histone deacetylase
12/15/2010CN101918384A Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
12/15/2010CN101918382A Bifeprunox derivatives
12/15/2010CN101918381A Substituted benzoazole PDE4 inhibitors for treating pulmonary and cardiovascular disorders
12/15/2010CN101918380A Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/15/2010CN101918379A Platinum complex compound and utilization of the same
12/15/2010CN101918378A Cyclic triazo and diazo sodium channel blockers
12/15/2010CN101918376A 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
12/15/2010CN101918374A 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
12/15/2010CN101918373A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
1 ... 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 ... 7860